Skip to content

Dietary Advanced Glycation End Products and Migraine

Are Dietary Intake of Advanced Glycation End Products and Migraine Associated? A Case-control Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05747911
Enrollment
120
Registered
2023-02-28
Start date
2022-02-01
Completion date
2023-03-01
Last updated
2023-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Disorders, Nutrition Disorders

Brief summary

Is dietary intake of advanced glycation different between individuals with and without migraine? Is there a difference between the groups in terms of energy and nutrients? The answers to these questions are sought.

Interventions

None listed

Sponsors

Karabuk University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* To be diagnosed with episodic migraine by an experienced neurologist, * For the control group, patients who were not diagnosed with migraine but applied to the headache outpatient clinic * Volunteer

Exclusion criteria

* Being younger than 19 years and older than 64 years of age, having a history of cardiovascular disease, hypertension, diabetes, cancer, liver and kidney disease or other neurological disorder (epilepsy, multiple sclerosis, stroke, traumatic brain injury, etc.), secondary headache, antilipidemic and glucose taking intolerance medications or vitamin-mineral supplements, following a special diet, and consuming less than 800 kcal or more than 4000 kcal per day

Design outcomes

Primary

MeasureTime frameDescription
Difference in dietary advanced glycation end products intake between groups2 monthsIs there a difference between the dietary intake of advanced glycation end products in individuals with migraine and healthy individuals? These values will be obtained from the food consumption records of the individuals. Intake of advanced glycation end product will be evaluated as ....kU/day. Is there a difference between the energy and nutrient intake of individuals with migraine and healthy individuals?

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026